Cullinan Management

Total Funding 

$389.7M

---

Cullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are developed via assets sourced internally through dry lab or externally through business, academic and pharma collaborations, enabling researchers to get a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model.

---

Number of employees

11-50

---

Headquarters

Cambridge, Massachusetts, United States